PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
13-May-2021 New tezepelumab data continue to strengthen profile for a broad population of severe asthma patients AstraZeneca and Amgen
13-May-2021 Positive Phase 3 Libtayo® (cemiplimab) results in advanced cervical cancer presented at ESMO Virtual Plenary Sanofi
13-May-2021 Biogen Announces Exercise of Option to Acquire the Investigational Drug TMS-007 for Acute Ischemic Stroke Based on Positive Phase 2a Data Biogen
12-May-2021 UK Manufacturing Facility & Phase III Trial Updates From Northwest Biotherapeutics (OTCQB: NWBO) Northwest Biotherapeutics
11-May-2021 Gelmetix closes successful £5 million capital raise, progresses to first-in-human trial Gelmetix
11-May-2021 Oxford Immunotec’s T-SPOT.COVID Test is Used in the COV-AD Clinical Study to Investigate the Immunological Response to SARS-CoV-2 Infection in Patients with Primary and Secondary Antibody Deficiency Oxford Immunotec
11-May-2021 Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate Novavax
10-May-2021 Bionomics Expanding BNC210 for Acute Treatment of Social Anxiety Disorder in Addition to Phase 2b Trial for PostTraumatic Stress Disorder Bionomics
10-May-2021 Global Prils Market is estimated to be US$ 3496.8 million by 2030 with a CAGR of 4.4% during the forecast period Prophecy Market Insights
07-May-2021 Imfinzi and tremelimumab with chemotherapy demonstrated overall survival benefit in POSEIDON trial for 1st-line Stage IV non-small cell lung cancer AstraZeneca
06-May-2021 Moderna Announces Positive Initial Booster Data Against SARS-CoV-2 Variants of Concern Moderna
06-May-2021 Parexel Achieves Top Rankings in Industry Across Multiple Attributes in ISR CRO Phase II-III Benchmarking Report Parexel
05-May-2021 TILT Biotherapeutics, Docrates Cancer Center and Helsinki University Hospital open cancer immunotherapy clinical trial TILT Biotherapeutics
05-May-2021 CMED GROUP joins AIXIAL GROUP, the CRO of ALTEN GROUP Scott PR
05-May-2021 Parexel Achieves Top Rankings in Industry Across Multiple Attributes in ISR CRO Phase II-III Benchmarking Report Parexel
04-May-2021 THREAD and Trialbee Partner to Enhance Global Decentralized Clinical Trial Inclusivity and Recruitment Outcomes Trialbee
04-May-2021 Farxiga approved in the US for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes Farxiga
04-May-2021 Pharmaceutical Intermediate Market projected to reach US$ 37,290.33 million by 2028 | Codexis, chiracon, Vertellus Holdings, Lianhe Chemical Technology, theinsightpartners
04-May-2021 Medical Cannabis Market Hits US$ 49,116.4 million by 2028 and to grow at a CAGR of 23.9% - Aphria, Aurora Cannabis, VIVO Cannabis, Tilray, CANVORY theinsightpartners
01-May-2021 Agilex Biolabs Congratulates Bionomics Limited on BNC210 PK Results Agilex Biolabs